Skip to main navigation Skip to search Skip to main content

De novo substitutions of TRPM3 cause intellectual disability and epilepsy

  • David A. Dyment
  • , Paulien A. Terhal
  • , Cecilie F. Rustad
  • , Kristian Tveten
  • , Christopher Griffith
  • , Parul Jayakar
  • , Marwan Shinawi
  • , Sara Ellingwood
  • , Rosemarie Smith
  • , Koen van Gassen
  • , Kirsty McWalter
  • , A. Micheil Innes
  • , Matthew A. Lines

Research output: Contribution to journalArticleAcademicpeer-review

3 Downloads (Pure)

Abstract

The developmental and epileptic encephalopathies (DEE) are a heterogeneous group of chronic encephalopathies frequently associated with rare de novo nonsynonymous coding variants in neuronally expressed genes. Here, we describe eight probands with a DEE phenotype comprising intellectual disability, epilepsy, and hypotonia. Exome trio analysis showed de novo variants in TRPM3, encoding a brain-expressed transient receptor potential channel, in each. Seven probands were identically heterozygous for a recurrent substitution, p.(Val837Met), in TRPM3’s S4–S5 linker region, a conserved domain proposed to undergo conformational change during gated channel opening. The eighth individual was heterozygous for a proline substitution, p.(Pro937Gln), at the boundary between TRPM3’s flexible pore-forming loop and an adjacent alpha-helix. General-population truncating variants and microdeletions occur throughout TRPM3, suggesting a pathomechanism other than simple haploinsufficiency. We conclude that de novo variants in TRPM3 are a cause of intellectual disability and epilepsy.

Original languageEnglish
Pages (from-to)1611-1618
JournalEuropean Journal of Human Genetics
Volume27
Issue number10
DOIs
Publication statusPublished - 1 Oct 2019

Fingerprint

Dive into the research topics of 'De novo substitutions of TRPM3 cause intellectual disability and epilepsy'. Together they form a unique fingerprint.

Cite this